Ellevest, Inc. Haemonetics Corp Transaction History

Ellevest, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$72.75 - $90.6 $509 - $634	-7 Reduced 77.78%	2 $0
Q4 2022 Feb 03, 2023	BUY	$73.85 - $86.14 $664 - $775	9 New	9 $0
Q2 2022 Jul 18, 2022	SELL	$49.27 - $66.08 $147 - $198	-3 Closed	0 $0
Q1 2022 Apr 19, 2022	BUY	$43.77 - $63.22 $131 - $189	3 New	3 $0
Q4 2021 Jan 24, 2022	SELL	$49.55 - $74.59 $1,288 - $1,939	-26 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$57.6 - $70.59 $1,497 - $1,835	26 New	26 $2,000
Q2 2021 Jul 13, 2021	SELL	$51.81 - $118.56 $310 - $711	-6 Closed	0 $0
Q3 2020 Oct 26, 2020	SELL	$75.65 - $93.58 $3,933 - $4,866	-52 Reduced 89.66%	6 $1,000
Q2 2020 Jul 06, 2020	BUY	$84.96 - $118.91 $4,927 - $6,896	58 New	58 $5,000

333

54M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.39B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.